CN102524635A - Ginseng-sweet tea extract and preparation method thereof - Google Patents
Ginseng-sweet tea extract and preparation method thereof Download PDFInfo
- Publication number
- CN102524635A CN102524635A CN2010106080815A CN201010608081A CN102524635A CN 102524635 A CN102524635 A CN 102524635A CN 2010106080815 A CN2010106080815 A CN 2010106080815A CN 201010608081 A CN201010608081 A CN 201010608081A CN 102524635 A CN102524635 A CN 102524635A
- Authority
- CN
- China
- Prior art keywords
- sweet
- tea
- theine
- ginseng
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to ginseng-sweet tea extract, a functional concentrated tea product, and a preparation method of the ginseng-sweet tea extract. The ginseng-sweet tea extract is composed of (by weight percentage) 3-25% of ginsenoside, 3-35% of sweet tea extracts which contain rubusoside and sweet tea flavone, 47-93% of major ingredient, concentrated extracts of original fermented tea that contain tea polysaccharide and soluble dietary fiber, and 1-3% of microcrystalline cellulose as the auxiliary. The preparation method comprises the following steps: drying and dehydrating the concentrated extracts of original fermented tea at a low temperature, and fully mixing the extracts with ginsenoside and rubusoside at room temperature, standing the mixture so as to make the tea polysaccharide and soluble dietary fiber of the original fermented tea combine with the rubusoside, the sweet tea flavone and the ginsenoside to form molecular groups; adding appropriate amount of microcrystalline cellulose to the fully mixed mixture and granulating to obtain an original product of ginseng-sweet tea extract. The ginseng-sweet tea extract of the invention can effectively regulate the endocrine disorders of human body, improve human immunity function, and regulate gastrointestinal tract, and have dietary therapeutic function on preventing and adjunctively treating diabetes and hypertension.
Description
Technical field
The present invention relates to a kind of embodiment that is suitable for practical novel instant sweet tea-sweet theine of ginseng of special populations such as diabetes, high fat of blood, hypertension, diabetes, gastroenteritis, endocrine Nutrition and Metabolism functional disturbance disease and preparation method thereof.
Background technology
The research background of joining sweet theine is under the background that present endocrine Nutrition and Metabolism functional disturbance (diabetes), high fat of blood, hypertension, gastroenteritis disease crowd not only increase and the research that launches.Recent statistics according to Ministry of Public Health's issue in 2010 shows: endocrine Nutrition and Metabolism functional disturbance 31.5 ‰, and wherein diabetes 27.5 ‰; Hypertension 31.4 ‰; The gastro-intestinal digestion tract disease accounts for 26.4 ‰.By Chinese Central Television's world's diabetes day on November 14th, 2010 report, the present diabetes number of patients of China is about more than 3,850 ten thousand people's crowd. above-mentioned disease grievous injury illness crowd's health, also caused disease patient's medical economics burden simultaneously.Research and development sweet theine raw material of ginseng and Related product are intended to satisfy pressing for of above-mentioned disease patient crowd for above-mentioned disease patient provides a kind of practicality economic sweet tea new product.
1. conopsea extraction (general ginsenoside)
TSPG is the main component of from the rhizome of araliaceae ginseng plant's genseng or American Ginseng, extracting, and disorder has regulatory function to this extract to human endocrine, and certain antidiabetic effect is arranged.
(1) ginsenoside has the effect of treatment diabetes
Through Zhang Huili researcher. professor Zheng Yinan confirms that to " research of anti-diabetic material in the American Ginseng " general ginsenoside that from the rhizome of American Ginseng, extracts has the effect of treatment diabetes, can significantly improve the insulin level in the serum.In the American ginseng extract, what certain antidiabetic effect was arranged is three kinds of saponin(es of ginsenoside Re .Rb1.Rb2.
The ginsenoside Re has hypoglycemic activity to the streptozotocin hyperglycemic rat; Rising to blood sugar behind the rat glucose load has inhibitory action.
(2) ginsenoside has the effect of adjusting to endocrine
Through Wang Junmo (the senior expert of Shanghai City retirement association pharmacy group) research panaxoside endocrine regulating action is shown: in the panaxoside, have only Rb1 can pass through hypothalamus or hypophysis are stimulated secretion ACTH, thereby increase adrenocortical CAMP.Through the synthetic and secretion of stimulation corticosteroid hormone in adrenal gland, thereby reach endocrine regulating action.Rather than directly acting on adrenal cortex, its effect increases with the increase of dosage.
2. sweet tea extract
Sweet tea extract comprises sweet theine, sweet tea flavones, in sweet theine be the main component of from Wild sweet tea, extracting.Sweet theine (rubusoside) is the main sweet ingredient of sweet tea, has another name called rubusoside.Its content (in mass percent) is about 5%, and by the tetracyclic diterpene glucoside that steviol and glucose are formed, its molecular formula is C
22H
50O
12
Sweet tea (RubussuavissimusS.Lee) is the rose family, rubus, and perennial fallen leaves wait-a-bit plant, its leaf flavor is sweet, mainly is distributed in area, Dayao Mountain, Guangxi.Guangxi is among the people uses existing long applicating history with sweet tea for tea-drinking.Practice among the people confirms, sweet tea relieves heat and thirst, moistening lung, kidney tonifying, function such as hypotensive and hypoglycemic, and particularly diabetic's long-term drinking can be achieved good results.
Through researchers such as the Tian Cuiping of life science institute of East China Normal University, Qu Weijing " sweet theine extract causes the hypoglycemic activity research of hyperglycemic rat to STZ " result is shown: the sweet theine of sweet tea extract can the utmost point reduces STZ significantly and causes hyperglycemic rat blood sugar; Strengthen its oxidation resistance, can stimulate secretion of insulin simultaneously.Conclusion: sweet theine extract reduces blood sugar through stimulating secretion of insulin.
Japanology finds, sweet tea has obvious curative effects to the control of diseases such as pollen hypersensitivity and other rhinitis, dermatitis.Sweet tea is natural to contain abundant human body beneficial's composition, and that wherein contained glycosides, sweet tea flavones have is hypotensive, hypoglycemic, regulate endocrine effect, and can enhance metabolism functions such as treatment hyperhydrochloria.Its sugariness of glycosides is 300 times of sucrose, and taste is considered to the easiest in human body acceptance, be high, the edible very safe natural sweet taste material of a kind of low heat value, sugariness, and sugariness is high, flavor matter is good, high temperature resistant.Patients such as obesity, diabetes, cardiovascular disease, hypertension, artery sclerosis there is certain auxiliary curative effect.
3. protozoa fermentation (pressing) tea concentrated extract
Protozoa fermentation (pressing) tea, be meant with in plucking, the thick tea of Da Ye is through nature, the tea product processed behind the biofermentation fully, is called fermented tea or ripe tea.
With fermented tea pulverize, dissolving, the extract that concentrates, produce after the low temperature drying, be exactly fermented tea extract.Show that through the related experiment analysis and research fermented tea extract main component is tea polysaccharide, dietary cellulosic (soluble dietary fiber is plain), Tea Polyphenols, accounts for more than 57% of concentrate.Tea polysaccharide 15%--21% wherein, Tea Polyphenols 8%---11%, (soluble dietary fiber is plain) 23%---27%.
Tea polysaccharide is that a kind of relative molecular mass is about 1 * 10^4～5 * 10^4 Water Soluble Compound polysaccharide, and main component has glucose, arabinose, ribose, galactolipin, glycosides to reveal sugar, wood sugar and fructose etc., and human body is had certain physiological function.
Through researchers such as Zhejiang University Tea department fourth benevolence phoenix " the hypoglycemic activity research of tea polysaccharide and Tea Polyphenols " is confirmed; Its conclusion is: the effect that tea polysaccharide has significant inhibition blood sugar to raise to hyperglycemic rat, the mechanism of action of tea polysaccharide possibly be to suppress small intestine sugar degrading enzyme activity.
Researcher such as Lu of Xuzhu City Inst. of Medical Science Aiwa Tian Lei shows the clinical research conclusion of " preparation of tea polysaccharide capsule preparations and the observation of hypoglycemic effect " through Jiangsu Province; A. this experiment is in recent years both at home and abroad to tea polysaccharide experimental research basis; Select for use coarse tea to extract the tea polysaccharide composition, the tea polysaccharide content and the yield that adopt this method for distilling to make are 30.2%.B. the tea polysaccharide glue of being developed assists preparation through the clinical efficacy preliminary observation, and the treatment group in the forward and backward blood sugar level of treatment relatively has explicitly difference (P＜0.05).Treatment group and contrast notable difference P＞0.05.Thereby verified the hypoglycemic clinical effectiveness of tea polysaccharide.
After deliberation: soluble dietary fiber is plain in the fermented tea, has the adjusting blood fat, the effect that helps enteral nutritional support into to digest and assimilate.
4. adjunct ingredient microcrystalline cellulose
The textile fiber of this strain is pressed dry product and is calculated through the powder that hydrolysis makes, and cellulose is 97.0%～102.0%.
Microcrystalline cellulose (mcc) is can free-pouring crystalline powder (non-fibrous particulate).Acid and most organic solvents of water insoluble, dilution are slightly soluble in 20% aqueous slkali.Of many uses aspect the pharmaceutical purpose auxiliary material, can directly be used for dry powder sheeting, be widely used as drug excipient, flow aid, filler, disintegrant, antiplastering aid, adsorbent, capsule diluent etc.
How mentioned component is effectively combined, make it to form better effect, and promote absorption of human body, then be still and need the technical task of researching and solving badly.
Summary of the invention
Technical problem to be solved by this invention provides the sweet theine of ginseng and the preparation method and the correlated product production method of a kind of suitable diabetes, high fat of blood, hypertension illness crowd needs.
For solving the problems of the technologies described above; The present invention provides the sweet tea raw material of a kind of new type natural to join sweet theine one by one; Its characteristic is TSPG 3%-25% by weight ratio mainly; The sweet tea extract 3%-35% that comprises sweet theine and sweet tea flavones comprises that the former fermented tea concentrated extract of tea polysaccharide and soluble dietary fiber 47%-93% forms as adjunct ingredient as main component and microcrystalline cellulose 1%--3%.
The present invention also provides the preparation method of the sweet theine of a kind of said ginseng, it is characterized in that may further comprise the steps:
Step 1; With former fermentation (pressing) tea concentrated extract; After the low temperature drying dehydration, under normal temperature condition, fully mix, leave standstill, make tea polysaccharide, soluble dietary fiber element in its former fermented tea concentrated extract be combined into molecule group with active ingredients such as sweet theine, panaxosides with panaxoside, sweet theine.
Step 2 with the abundant mixture that step 1 obtains, is granulated after adding an amount of microcrystalline cellulose adjunct ingredient, promptly obtains joining sweet theine raw produce.
With the sweet theine raw material of the ginseng that makes, processing by required formulation process needs formulation.Preparation can have electuary, capsule, tablet, four kinds of formulations of granula.
The sweet theine of ginseng of the present invention is on the experiment basis according to research associated biomolecule composition of raw material, functional character; Through demonstration, experimental study and the new special tea product that designs; Be to have the nature sweet taste and the special sugared source with hypoglycemic activity can be provided, satisfy glycosuria sugar patient's specific demand.Join sweet theine and can effectively regulate the human body endocrinopathy, improve the human immunologic function, regulate intestines and stomach, have dietary function aspect prevention, adjuvant therapy of diabetes, the hypertension.
The specific embodiment
Joining sweet theine is TSPG 3%-25% by weight ratio; The sweet tea extract 3%-35% that comprises sweet theine and sweet tea flavones comprises that the former fermented tea concentrated extract of tea polysaccharide and soluble dietary fiber 47%-93% forms as adjunct ingredient as main component and microcrystalline cellulose 1%--3%.
Sweet theine preparation method is joined in practical implementation: be the present invention to be joined sweet theine related raw material after normal temperature, gnotobasis condition are descended 100 mesh sieves and mixed, left standstill, make active ingredients such as its tea polysaccharide, panaxoside, sweet theine be combined into molecule group; The mixture of fully mixing thoroughly is added an amount of microcrystalline cellulose granulate, promptly obtain joining sweet theine raw produce.The sweet theine raw material of ginseng with this preparation method processes carries out aseptic process, metering, compressing tablet, processes the tablet product.
Below enumerate the specific embodiment of the invention:
Instance 1, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 3% panaxoside, 3% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 93% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 1% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 2, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves. under normal temperature, drying, gnotobasis state, operate production (1): 25% panaxoside, 3% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 69% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 3% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 3, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 25% panaxoside, 35% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 47% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 3% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 4, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 3% panaxoside, 35% sweet tea extract (sweet theine meter) are fully mixed, leave standstill in the factory formula ratio with 61% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 1% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 5, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 5% panaxoside, 10% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 83% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 2% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 6, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 10% panaxoside, 15% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 74% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 2% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 7, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 15% panaxoside, 15% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 68% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 2% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 8, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 10% panaxoside, 15% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 73% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 2% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 9, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 15% panaxoside, 20% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 64% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 1% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 10, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 25% panaxoside, 3% sweet tea extract are fully mixed, leave standstill in the factory formula ratio with 70% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 2% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
Instance 11, will join sweet theine related raw material general ginsenoside, sweet tea extract (sweet theine, sweet tea flavones), former fermented tea concentrated extract dry powder raw materials such as (tea polysaccharide, soluble dietary fibers) and cross 100 mesh sieves.Under normal temperature, drying, gnotobasis state, operate production (1): 8% panaxoside, 14% sweet tea extract (sweet theine meter) are fully mixed, leave standstill in the factory formula ratio with 78% former fermented tea concentrated extract, make its general ginsenoside, sweet theine and tea polysaccharide, soluble dietary fiber fully be combined into molecule group; (2): the mixture of (1) evenly mixed, granulates with 2% microcrystalline cellulose auxiliary material promptly obtains joining sweet theine original product.
The sweet theine original product of the ginseng that is prepared into is carried out aseptic process, metering, compressing tablet, processes the tablet product.Join sweet theine tablet, 60 of per one box-packed amounts (0.5gx12 grain x5 version), net content 30g meter.
The sweet theine of ginseng of the present invention is special tea product, and the special sugared source with hypoglycemic activity can be provided.Its prescription theory of constitution science, reasonable, constituents such as its general ginsenoside, sweet theine, tea polysaccharide all have certain hypoglycemic activity.Soluble dietary fiber in its fermented tea extract is plain, has the effect of regulating gastrointestinal function.Being fit to special populations such as high fat of blood, diabetes, endocrine disturbance, gastrointestinal function imbalance uses.The eating method that comprises the sweet theine of ginseng of the present invention of the foregoing description is: every day 2--3 time, each 1--2 sheet is got these article 1--2 sheet before the meal, puts into and drinks after the cup temperature of falling 200lm--300lm boiling water is waited to dissolve.
Claims (4)
1. the sweet theine of a seed ginseng; It is characterized in that; By weight ratio is TSPG 3%-25%; The sweet tea extract 3%-35% that comprises sweet theine and sweet tea flavones comprises that the former fermented tea concentrated extract 47%-93% of tea polysaccharide and soluble dietary fiber forms as adjunct ingredient as main component and microcrystalline cellulose 1%--3%.
2. the sweet theine constitutive material of ginseng according to claim 1, said panaxoside composition extract from American Ginseng; Said sweet tea extract belongs to the concentrated extract of natural sweet taste plant Wild sweet tea for rose family stirrup; Said former fermented tea concentrated extract is full fermented tea concentrated extract.
3. the preparation method of the sweet theine of ginseng according to claim 1 and 2 is characterized in that may further comprise the steps:
Step 1; With said former fermented tea concentrated extract; After the low temperature drying dehydration, under normal temperature condition, fully mix, leave standstill, make tea polysaccharide, soluble dietary fiber element in its former fermented tea concentrated extract be combined into molecule group with sweet theine, sweet tea flavones, panaxoside composition with panaxoside, sweet theine;
Step 2 with the abundant mixture that step 1 obtains, is granulated after adding an amount of microcrystalline cellulose, promptly obtains joining sweet theine original product.
4. the preparation method of the sweet theine of ginseng according to claim 3 is characterized in that further comprising the steps of: the sweet theine original product of the ginseng that will make, process electuary, capsule, tablet or four kinds of formulations of granula by required formulation process.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106080815A CN102524635A (en) | 2010-12-27 | 2010-12-27 | Ginseng-sweet tea extract and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106080815A CN102524635A (en) | 2010-12-27 | 2010-12-27 | Ginseng-sweet tea extract and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102524635A true CN102524635A (en) | 2012-07-04 |
Family
ID=46333679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010106080815A Pending CN102524635A (en) | 2010-12-27 | 2010-12-27 | Ginseng-sweet tea extract and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102524635A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106333978A (en) * | 2016-08-31 | 2017-01-18 | 湖南中振生物科技股份有限公司 | Lithocarpus polystachyus instant tea for invigorating qi and decreasing blood sugar and preparation method thereof |
| CN112515014A (en) * | 2020-12-03 | 2021-03-19 | 紫物境界(十堰市武当山旅游经济特区)农业科技有限公司 | Kudzuvine root polysaccharide sweet zong black tea and preparation method thereof |
| CN113214413A (en) * | 2021-06-02 | 2021-08-06 | 成都农业科技中心 | Sweet tea polysaccharide extract with high antioxidant activity and extraction method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1370472A (en) * | 2002-01-25 | 2002-09-25 | 云南省天然药物中心 | Health food with blood pressure and blood lipoid regulating function and its production process |
| CN1911329A (en) * | 2006-08-11 | 2007-02-14 | 杨德华 | Traditional Chinese medicine composition for preventing and/or adjuvant therapy of malignant tumor |
| CN101120706A (en) * | 2007-08-02 | 2008-02-13 | 史涛涛 | Tea for morning-getting-up health-preserving |
| CN101569692A (en) * | 2009-05-23 | 2009-11-04 | 三亚市南繁科学技术研究院 | Compound health herb tea |
-
2010
- 2010-12-27 CN CN2010106080815A patent/CN102524635A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1370472A (en) * | 2002-01-25 | 2002-09-25 | 云南省天然药物中心 | Health food with blood pressure and blood lipoid regulating function and its production process |
| CN1911329A (en) * | 2006-08-11 | 2007-02-14 | 杨德华 | Traditional Chinese medicine composition for preventing and/or adjuvant therapy of malignant tumor |
| CN101120706A (en) * | 2007-08-02 | 2008-02-13 | 史涛涛 | Tea for morning-getting-up health-preserving |
| CN101569692A (en) * | 2009-05-23 | 2009-11-04 | 三亚市南繁科学技术研究院 | Compound health herb tea |
Non-Patent Citations (6)
| Title |
|---|
| 刘霞林: "茶叶中糖类研究进展", 《福建茶叶》, no. 03, 30 September 2004 (2004-09-30) * |
| 周杨等: "云南普洱茶多糖提取工艺及翻堆样中含量测定的研究", 《食品科技》, no. 06, 20 June 2007 (2007-06-20) * |
| 柏芸等: "蔷薇科甜茶加工应用研究进展", 《农产品加工(创新版)》, no. 11, 30 November 2010 (2010-11-30) * |
| 瞿茂生等: "国内外对人参代用品绞股蓝的研究及栽培利用", 《湖南林业科技》, no. 02, 28 February 1989 (1989-02-28) * |
| 邓绍林: "广西甜茶叶片的营养成分及开发利用价值研究", 《中国林副特产》, no. 03, 20 August 2000 (2000-08-20) * |
| 黎海彬等: "苦丁茶绞股蓝保健饮料的研制", 《山西食品工业》, no. 01, 31 March 2001 (2001-03-31) * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106333978A (en) * | 2016-08-31 | 2017-01-18 | 湖南中振生物科技股份有限公司 | Lithocarpus polystachyus instant tea for invigorating qi and decreasing blood sugar and preparation method thereof |
| CN112515014A (en) * | 2020-12-03 | 2021-03-19 | 紫物境界(十堰市武当山旅游经济特区)农业科技有限公司 | Kudzuvine root polysaccharide sweet zong black tea and preparation method thereof |
| CN113214413A (en) * | 2021-06-02 | 2021-08-06 | 成都农业科技中心 | Sweet tea polysaccharide extract with high antioxidant activity and extraction method thereof |
| CN113214413B (en) * | 2021-06-02 | 2022-11-25 | 中国农业科学院都市农业研究所 | Sweet tea polysaccharide extract with high antioxidant activity and extraction method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102380051B (en) | Medicinal steamed bread for treating diabetes | |
| CN102458434B (en) | Composition for increasing the bioavailability of saponin | |
| CN103285231A (en) | Medicine composition for diabetes adjunctive therapy and preparation method thereof | |
| CN101450166A (en) | Traditional Chinese medicine composition with blood-sugar function and preparation method thereof | |
| CN102599322A (en) | Tablet candy suitable for children and manufacturing method thereof | |
| CN111840363B (en) | Natto-assisted hypoglycemic health-care composition and preparation method and application thereof | |
| CN103734751A (en) | Composite dietary fiber and preparation method thereof | |
| CN104543834A (en) | Pumpkin powder with blood sugar reducing effect and preparation method thereof | |
| CN101829209B (en) | Preparation method of fruit-flavored sweet tea polyphenols | |
| CN105053955A (en) | Blood-glucose-reducing sweetening agent without lingering bitterness | |
| CN104173451B (en) | The application in blood sugar lowering medicine and health food of a kind of natural drug composition | |
| CN103830496A (en) | Blood glucose reduction resistant composition | |
| CN102524635A (en) | Ginseng-sweet tea extract and preparation method thereof | |
| CN103349121A (en) | Hyperglycemia-hyperlipidemia-hypertension relieving health protection tea and preparation method thereof | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN107836619A (en) | A kind of beautiful millettia root solid beverage with strengthen immunity and antifatigue effect and preparation method thereof | |
| CN101731401B (en) | Polygonatum instant tea and preparation method thereof | |
| CN104115960A (en) | Fresh reed rhizome herbal tea beverage | |
| CN106581166A (en) | Anti-fatigue food, health product or pharmaceutical composition | |
| CN105831318A (en) | Polypeptide tea for blood glucose reduction and manufacturing method of polypeptide tea | |
| CN105267662A (en) | Okra and fenugreek health tea and preparation method thereof | |
| CN104825821A (en) | Medicine for treating diabetes and preparation method thereof | |
| CN107737280A (en) | Chinese medicine composition for treating diabetes and its preparation method and application | |
| CN108567854A (en) | Join Ling oral liquid and preparation method thereof | |
| CN101912460B (en) | Preparation method for improving ginsenoside-containing Chinese medicinal extract quality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120704 |